scholarly journals Protective Effect of Se-Methylselenocysteine on Elaidic Acid-Induced Inflammation in Human Arterial Endothelial Cells

2020 ◽  
Vol 66 (6) ◽  
pp. 577-582
Author(s):  
Jizhu XIA ◽  
Xiaorong XIA ◽  
Wenyuan WANG ◽  
Jiyi XIA ◽  
Mingxing LI
Keyword(s):  
Endothelial Cells ◽  
Protective Effect ◽  
Elaidic Acid ◽  
Arterial Endothelial Cells

Dextran Sulphates Protect Porcine Arterial Endothelial Cells from Free Radical Injury

1994 ◽  
Vol 13 (4) ◽  
pp. 233-239 ◽  
Author(s):  
Linda M. Hiebert ◽  
Ji-Min Liu
Keyword(s):  
Hydrogen Peroxide ◽  
Endothelial Cells ◽  
Free Radical ◽  
Protective Effect ◽  
Cell Damage ◽  
Average Molecular Weight ◽  
Dextran Sulphate ◽  
Trypan Blue Exclusion ◽  
Arterial Endothelial Cells ◽  
Cell Medium

1 The ability of dextran sulphate to protect cultured porcine arterial endothelial cells injured by addition of xanthine and xanthine oxidase (X/XO) or hydrogen peroxide to cell medium was examined using a variety of drug preparations. Cell damage was assessed by determining cell viability (by trypan blue exclusion) and release of lactate dehydrogenase into the medium. 2 Dextran sulphates of average molecular weight (Mr) 5000, 8000 (hydrogenated or unhydrogenated) at 0.05, 0.5, 5 and 50 μg ml-1 medium, added 24 h prior to X/XO, protected cells, whereas dextran sulphate Mr 500,000 was protective only at 0.5 μg ml-1. 3 None of the dextran sulphates used showed any toxic effect on cells in concentrations up to 500 μg ml-1 medium. 4 When the duration of pretreatment with dextran sulphate Mr 8000 was varied, 6 h was required for a protective effect on cells damaged by X/XO, which was enhanced with durations of 16 and 24 h. 5 Dextran sulphates had a similar protective effect on cells damaged by hydrogen peroxide. 6 This study suggests that dextran sulphates may prevent conditions resulting from free radical injury.

Culture of Arterial Endothelial Cells

1975 ◽  
Vol 34 (03) ◽  
pp. 825-839 ◽  
Author(s):  
Francois M Booyse ◽  
Bonnie J Sedlak ◽  
Max E Rafelson
Keyword(s):  
Endothelial Cells ◽  
Calf Serum ◽  
Intercellular Junctions ◽  
Cell Number ◽  
Population Doubling ◽  
Homogeneous Population ◽  
Bovine Endothelial Cells ◽  
Pinocytotic Vesicles ◽  
Arterial Endothelial Cells ◽  
Doubling Times

SummaryArterial endothelial cells were obtained from bovine aortae by mild treatment with collagenase and medium perfusion. These cells were cultured in RPMI-1640 medium containing 15 mM Hepes buffer and 35% fetal calf serum at pH 7.35. Essentially ah (90–95%) the effluent cells were viable and 80% of these cells attached to the substratum within 1 hour. Small patches of attached cells coalesced to form confluent monolayers in 3–5 days. Confluent monolayers of endothelial cells consisted of a homogeneous population of tightly packed, polygonal cells. Selected cultures were serially subcultured (trypsin-EDTA) for 12–14 months (30–35 passages) without any apparent change in morphology or loss of growth characteristics. Primary and three-month old (15 passages) cultures had population doubling times of 32–34 hours and 29–31 hours, respectively. These cells (primary and subcultures) did not require a minimum cell number to become established in culture. Bovine endothelial cells (primary, first, fifth and thirteenth passages) were characterized ultrastructurally by the presence of Weibel-Palade bodies, pinocytotic vesicles and microfilaments and immunologically by the presence of thrombosthenin-like contractile proteins and Factor VIII antigen. The intercellular junctions of post-confluent cultures stained specifically with silver nitrate. From these data, we concluded that identifiable endothelial cells could be obtained from bovine aortae and cultured and maintained for prolonged periods of time.

scholarly journals Venous and Arterial Endothelial Cells from Human Umbilical Cords: Potential Cell Sources for Cardiovascular Research

2021 ◽  
Vol 22 (2) ◽  
pp. 978
Author(s):  
Skadi Lau ◽  
Manfred Gossen ◽  
Andreas Lendlein ◽  
Friedrich Jung
Keyword(s):  
Endothelial Cells ◽  
Umbilical Cord ◽  
Membrane Integrity ◽  
Cell Types ◽  
Cell Number ◽  
Human Umbilical Cord ◽  
Cardiovascular Research ◽  
Cardiovascular Devices ◽  
Arterial Endothelial Cells

Although cardiovascular devices are mostly implanted in arteries or to replace arteries, in vitro studies on implant endothelialization are commonly performed with human umbilical cord-derived venous endothelial cells (HUVEC). In light of considerable differences, both morphologically and functionally, between arterial and venous endothelial cells, we here compare HUVEC and human umbilical cord-derived arterial endothelial cells (HUAEC) regarding their equivalence as an endothelial cell in vitro model for cardiovascular research. No differences were found in either for the tested parameters. The metabolic activity and lactate dehydrogenase, an indicator for the membrane integrity, slightly decreased over seven days of cultivation upon normalization to the cell number. The amount of secreted nitrite and nitrate, as well as prostacyclin per cell, also decreased slightly over time. Thromboxane B2 was secreted in constant amounts per cell at all time points. The Von Willebrand factor remained mainly intracellularly up to seven days of cultivation. In contrast, collagen and laminin were secreted into the extracellular space with increasing cell density. Based on these results one might argue that both cell types are equally suited for cardiovascular research. However, future studies should investigate further cell functionalities, and whether arterial endothelial cells from implantation-relevant areas, such as coronary arteries in the heart, are superior to umbilical cord-derived endothelial cells.

Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells

2006 ◽  
Vol 40 (6) ◽  
pp. 952-959 ◽  
Author(s):  
Eric E. Kelley ◽  
Thomas Hock ◽  
Nicholas K.H. Khoo ◽  
Gloria R. Richardson ◽  
Kamorris K. Johnson ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Xanthine Oxidoreductase ◽  
Oxidoreductase Activity ◽  
Moderate Hypoxia ◽  
Arterial Endothelial Cells

Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells

2004 ◽  
Vol 287 (1) ◽  
pp. L60-L68 ◽  
Author(s):  
Louis G. Chicoine ◽  
Michael L. Paffett ◽  
Tamara L. Young ◽  
Leif D. Nelin
Keyword(s):  
Nitric Oxide ◽  
Endothelial Cells ◽  
No Synthase ◽  
No Production ◽  
Urea Production ◽  
Pulmonary Arterial ◽  
Factor Α ◽  
Arterial Endothelial Cells ◽  
Regular Medium ◽  
Necrosis Factor

Nitric oxide (NO) is produced by NO synthase (NOS) from l-arginine (l-Arg). Alternatively, l-Arg can be metabolized by arginase to produce l-ornithine and urea. Arginase (AR) exists in two isoforms, ARI and ARII. We hypothesized that inhibiting AR with l-valine (l-Val) would increase NO production in bovine pulmonary arterial endothelial cells (bPAEC). bPAEC were grown to confluence in either regular medium (EGM; control) or EGM with lipopolysaccharide and tumor necrosis factor-α (L/T) added. Treatment of bPAEC with L/T resulted in greater ARI protein expression and ARII mRNA expression than in control bPAEC. Addition of l-Val to the medium led to a concentration-dependent decrease in urea production and a concentration-dependent increase in NO production in both control and L/T-treated bPAEC. In a second set of experiments, control and L/T bPAEC were grown in EGM, EGM with 30 mM l-Val, EGM with 10 mM l-Arg, or EGM with both 10 mM l-Arg and 30 mM l-Val. In both control and L/T bPAEC, treatment with l-Val decreased urea production and increased NO production. Treatment with l-Arg increased both urea and NO production. The addition of the combination l-Arg and l-Val decreased urea production compared with the addition of l-Arg alone and increased NO production compared with l-Val alone. These data suggest that competition for intracellular l-Arg by AR may be involved in the regulation of NOS activity in control bPAEC and in response to L/T treatment.

Venous and arterial endothelial cells respond differently to thrombin and its endogenous receptor agonist

1992 ◽  
Vol 216 (1) ◽  
pp. 135-137 ◽  
Author(s):  
Serge Simonet ◽  
Edith Bonhomme ◽  
Michel Laubie ◽  
Christophe Thurieau ◽  
Jean-Luc Fauchère ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Receptor Agonist ◽  
Arterial Endothelial Cells
Sign in / Sign up

Export Citation Format

Share Document